Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 283 followers
Latest posts
Last updated about 11 hours ago
Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 47, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of...
Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation: 12/02/2025, Revision: 1, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Welireg, belzutifan, Date of authorisation...
Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 13, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation...
Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 9, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation...
Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga) chloride, Date of authorisation: 08/01/2026, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): GalenVita, germanium (68Ge) chloride,gallium (68Ga)...
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Date of authorisation: 17/10/2025, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Winlevi, clascoterone, Date of authorisation...
Human medicines European public assessment report (EPAR): Voydeya, danicopan, Date of authorisation: 19/04/2024, Revision: 3, Status: Authorised
about 15 hours ago
Human medicines European public assessment report (EPAR): Voydeya, danicopan, Date of authorisation...
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 25, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation...
Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 27, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation...
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation: 26/05/2016, Revision: 26, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Neparvis, sacubitril,valsartan, Date of authorisation...
Human medicines European public assessment report (EPAR): Celsentri, maraviroc, Date of authorisation: 18/09/2007, Revision: 32, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Celsentri, maraviroc, Date of authorisation...
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation: 03/02/2025, Revision: 4, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Hetronifly, serplulimab, Date of authorisation...